ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,761Medicare Part D Prescriptions Filled, Including Refills

Rank: 545 out of 2588

$499K Total Retail Price of All Prescriptions

Rank: 471 out of 2588

214 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 214 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 7,204 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
AMLODIPINE BESYLATE 338 332 1 4
SIMVASTATIN 269 239 2 1
NEXIUM 256 248 3 41
METFORMIN HCL 251 234 4 8
ATORVASTATIN CALCIUM 200 194 5 11
LEVOTHYROXINE SODIUM 199 175 6 2
METOPROLOL SUCCINATE 187 176 7 12
FAMOTIDINE 178 142 8 36
ALENDRONATE SODIUM 177 162 9 21
BYSTOLIC 152 147 10 110
LOVAZA 152 143 10 119
WARFARIN SODIUM 139 120 12 10
DIOVAN 127 110 13 29
OMEPRAZOLE 117 115 14 6
DIOVAN HCT 112 112 15 72
LANSOPRAZOLE 109 99 16 157
ZOLPIDEM TARTRATE 104 104 17 24
GLIPIZIDE XL 102 94 18 140
CARVEDILOL 99 99 19 20
TRIAMTERENE-HCTZ 98 92 20 46
JANUVIA 97 84 21 60
LIDODERM 87 87 22 86
METOPROLOL TARTRATE 86 82 23 9
TAMSULOSIN HCL 85 84 24 23
CLONIDINE HCL 85 85 24 54
SYNTHROID 84 75 26 88
TRAMADOL HCL 81 81 27 19
BENICAR 75 75 28 143
CLOPIDOGREL 72 70 29 30
GLIPIZIDE ER 71 41 30 73
LOSARTAN-HYDROCHLOROTHIAZIDE 66 62 31 66
MECLIZINE HCL 64 64 32 120
VOLTAREN 63 49 33 161
ISOSORBIDE MONONITRATE ER 62 62 34 49
BENICAR HCT 62 62 34 187
ATENOLOL 61 50 36 14
PLAVIX 58 58 37 43
ENALAPRIL MALEATE 55 47 38 31
PROAIR HFA 53 53 39 50
TRICOR 52 52 40 122
FLUTICASONE PROPIONATE 51 38 41 40
TERBINAFINE HCL 51 39 41 374
POLYETHYLENE GLYCOL 3350 50 50 43 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 2, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.